Evonik Industries AG (SWX:EVK)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
15.13
0.00 (0.00%)
At close: Jun 3, 2026
Market Cap7.18B -18.4%
Revenue (ttm)12.69B -9.4%
Net Income145.20M -47.5%
EPS0.31 -47.6%
Shares Out n/a
PE Ratio49.44
Forward PE11.58
Dividend1.00 (6.61%)
Ex-Dividend DateJun 4, 2026
Volumen/a
Openn/a
Previous Close15.13
Day's Rangen/a
52-Week Range12.57 - 16.13
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateMay 8, 2026

About Evonik Industries AG

Evonik Industries AG operates as a chemicals company in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. It operates through the Advanced Technologies, Custom Solutions, and Infrastructure segments. The Advanced Technologies segment provides polymers for medical applications; crosslinkers; hydrogen peroxide, a sterilizing agent for cleaning silicon wafers and a bleaching agent for the paper and textile industries; fumed and precipitated silicas and silanes for the automotive, tire, electronics, and cosmetics industries; and ... [Read more]

Industry Chemicals
Sector Materials
Founded 1847
Employees 30,643
Stock Exchange SIX Swiss Exchange
Ticker Symbol EVK

Financial Performance

In 2025, Evonik Industries AG's revenue was 14.07 billion, a decrease of -7.18% compared to the previous year's 15.16 billion. Earnings were 265.00 million, an increase of 19.37%.

Financial numbers in EUR Financial Statements

News

Evonik Industries AG Transcript: AGM 2026

The meeting addressed leadership changes, a challenging financial year, and a shift to a performance-based dividend policy. Strategic initiatives focus on innovation, cost discipline, and green transformation, with continued investment in growth areas.

1 day ago - Transcripts

Evonik Industries AG Earnings Call Transcript: Q1 2026

Q1 2026 adjusted EBITDA exceeded expectations at EUR 475 million, driven by strong Advanced Technologies and pre-buying effects, while free cash flow remained robust. Q2 EBITDA is guided to at least EUR 550 million, but risks from inflation and supply chain disruptions persist.

27 days ago - Transcripts

Evonik Industries AG Slides: Q1 2026

Evonik Industries AG has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 8, 2026.

27 days ago - Filings

Evonik Industries AG Quarterly report: Q1 2026

Evonik Industries AG has published its Q1 2026 quarterly earnings report on May 8, 2026.

27 days ago - Filings

Evonik Industries AG Earnings release: Q1 2026

Evonik Industries AG released its Q1 2026 earnings on May 8, 2026, summarizing the period's financial results.

27 days ago - Filings

Evonik Industries AG Slides: Company presentation

Evonik Industries AG has posted slides in relation to its latest quarterly earnings report, which was published on May 8, 2026.

27 days ago - Filings

Evonik Industries AG Earnings release: Q4 2025

Evonik Industries AG released its Q4 2025 earnings on March 4, 2026, summarizing the period's financial results.

3 months ago - Filings

Evonik Industries AG Annual report: Q4 2025

Evonik Industries AG has published its Q4 2025 annual report on March 4, 2026.

3 months ago - Filings

Evonik Industries AG Annual report: Q4 2025

Evonik Industries AG has published its Q4 2025 annual report on March 4, 2026.

3 months ago - Filings

Evonik Industries AG Slides: Q4 2025

Evonik Industries AG has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 4, 2026.

3 months ago - Filings

Evonik Industries AG Slides: Sustainability presentation

Evonik Industries AG has posted slides in relation to its latest quarterly earnings report, which was published on March 4, 2026.

3 months ago - Filings

Evonik Industries AG Slides: Investor presentation

Evonik Industries AG has posted slides in relation to its latest quarterly earnings report, which was published on March 4, 2026.

3 months ago - Filings

Evonik Industries AG Earnings Call Transcript: Q4 2025

Delivered solid 2025 results with EUR 1.9 billion adjusted EBITDA and strong cash flow. 2026 guidance targets stable earnings amid persistent weak demand, cost savings, and a new flexible dividend policy. Regulatory and market changes, especially in methionine and Oxeno, will shape performance.

4 months ago - Transcripts

Evonik Industries AG Earnings release: Q4 2025

Evonik Industries AG released its Q4 2025 earnings on February 5, 2026, summarizing the period's financial results.

4 months ago - Filings

Evonik Industries AG Slides: Q4 2025

Evonik Industries AG has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 5, 2026.

4 months ago - Filings

Evonik Industries AG Earnings Call Transcript: Q3 2025

Q3 results were weak, leading to a revised full-year EBITDA guidance of EUR 1.9 billion, but confidence remains in meeting targets due to strong healthcare and Animal Nutrition recovery. Structural cost savings, new plant ramp-ups, and the SYNEQT carve-out are expected to support future performance despite ongoing market challenges.

7 months ago - Transcripts

Evonik Industries AG Quarterly report: Q3 2025

Evonik Industries AG has published its Q3 2025 quarterly earnings report on November 4, 2025.

7 months ago - Filings

Evonik Industries AG Slides: Q3 2025

Evonik Industries AG has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 4, 2025.

7 months ago - Filings

Evonik Industries AG Earnings Call Transcript: Q2 2025

Q2 results were resilient despite macro headwinds, with core segments stable and cost savings underway. Full-year guidance is maintained at the lower end, but achieving it depends on macro improvement and strict cost controls.

10 months ago - Transcripts

Evonik Industries AG Quarterly report: Q2 2025

Evonik Industries AG has published its Q2 2025 quarterly earnings report on August 1, 2025.

10 months ago - Filings

Evonik Industries AG Slides: Q2 2025

Evonik Industries AG has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 1, 2025.

10 months ago - Filings

Evonik to Cut 6% of Workforce

Evonik said it would cut up to 2,000 jobs by 2026, expecting cost reductions of around €400 million, after its fourth-quarter underlying earnings came in slightly below consensus forecasts.

2 years ago - WSJ

Evonik says recovery unlikely in 2024, plans 2,000 job cuts

German chemicals group Evonik Industries said on Monday it expected no signs of a recovery in 2024 and announced up to 2,000 job cuts worldwide by 2026 in a bid to cut costs.

2 years ago - Reuters

Germany's Economy Is in a Bad Slump. These 6 Stocks Could Rebound.

Look for companies that have been bearing the brunt of the pain to pull out stronger.

2 years ago - Barrons